Fortress Biotech, Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Fortress Biotech, Inc. (FBIO) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2022-03-28
- Fortress Biotech, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2021 was $0.00.
- Fortress Biotech, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2020 was $0.00.
- Fortress Biotech, Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2012 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-28 |
| 2020-12-31 | $0.00 10-K/A · filed 2021-04-09 |
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |